Drug Type Gene therapy |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Nucleome Therapeutics Ltd.Startup |
Active Organization Nucleome Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | GB | Nucleome Therapeutics Ltd.Startup | 24 Apr 2024 |
Systemic Lupus Erythematosus | Preclinical | GB | Nucleome Therapeutics Ltd.Startup | 24 Apr 2024 |